yeast-derived beta-glucan supplement
Term · Oncology and biomedicine · MLC-T-ONC-017613
A dietary supplement composed of yeast-derived beta-glucan, with potential antioxidant, anti-inflammatory and immunomodulatory activities. Upon administration of yeast-derived beta-glucan supplement, beta-glucan may decrease both superoxide dismutase and reductase activities and the release of pro-inflammatory cytokines, thereby reducing oxidative stress and inflammation. Beta-glucan may also stimulate the immune system by binding to a lectin site within the complement receptor 3 (CR3 or iC3b receptor) on leukocytes, priming the receptor to trigger cytotoxic degranulation of leukocytes when leukocyte CR3 binds to iC3b-opsonized cells. iC3b is the proteolyticly inactive product of the complement cleavage fragment C3b.
| Identifier | MLC-T-ONC-017613 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | yeast-derived beta-glucan |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017613",
"term": "yeast-derived beta-glucan supplement",
"field": "Oncology and biomedicine",
"definition": "A dietary supplement composed of yeast-derived beta-glucan, with potential antioxidant, anti-inflammatory and immunomodulatory activities. Upon administration of yeast-derived beta-glucan supplement, beta-glucan may decrease both superoxide dismutase and reductase activities and the release of pro-inflammatory cytokines, thereby reducing oxidative stress and inflammation. Beta-glucan may also stimulate the immune system by binding to a lectin site within the complement receptor 3 (CR3 or iC3b receptor) on leukocytes, priming the receptor to trigger cytotoxic degranulation of leukocytes when leukocyte CR3 binds to iC3b-opsonized cells. iC3b is the proteolyticly inactive product of the complement cleavage fragment C3b.",
"synonyms": [
"yeast-derived beta-glucan"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/yeast-derived-beta-glucan-supplement/"
}
Record 17,535 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.